Nurse Practitioner, Family · Wakarusa, KS
NPI
1528505229
Since 2017
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
5823 SW 85th St
Wakarusa, KS, 66546
Phone (785) 817-3944
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.4M
8,025 prescriptions
Company payments, 2025
$90.73
From 3 companies
Medicare prescription drug claims, 2024
In 2024, the drug Daniel Keck prescribed most often to Medicare patients was Levothyroxine Sodium, with 521 prescriptions and refills. In total Daniel Keck wrote 8,025 Medicare prescriptions that cost $1.4M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-19.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 521 | 521 | 55 | $7,936 |
| Omeprazole Generic | 221 | 221 | 22 | $2,318 |
| Lamotrigine Generic | 217 | 217 | 17 | $3,209 |
| Baclofen Generic | 200 | 200 | 17 | $7,957 |
| Glycopyrrolate Generic | 199 | 199 | 22 | $8,396 |
| Levetiracetam Generic | 195 | 195 | 20 | $17K |
| Atorvastatin Calcium Generic | 188 | 188 | 18 | $2,560 |
| Potassium Chloride Generic | 172 | 174 | 19 | $61K |
| Risperidone Generic | 169 | 169 | 12 | $2,470 |
| Furosemide Generic | 160 | 160 | 19 | $903 |
| Simvastatin Generic | 159 | 159 | 15 | $900 |
| Tamsulosin Hcl Generic | 146 | 146 | 15 | $3,341 |
| Lorazepam Generic | 145 | 145 | 38 | $564 |
| Fluticasone Propionate Generic | 142 | 184 | 21 | $3,438 |
| Valproic Acid Valproic Acid (As Sodium Salt) | 138 | 139 | 13 | $14K |
Brand drugs: 1,192 claims; generic drugs: 6,721 claims; opioid claims: 46.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Daniel Keck $90.73 ($90.73 in general payments such as food, travel and fees) from 3 companies. The largest payer was Jazz Pharmaceuticals Inc. with $31.09.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.